Table 4.
Statistical analysis of data presented in Fig. 5. Post hoc results are only shown for tests which reached statistical significance (P < 0.05)
DF | eta squared Cohen’s d | F (DFn, DFd) t | P value | |
---|---|---|---|---|
Gonads (two-way) | ||||
Interaction | 3 | 17.8 | F (3, 38) = 5.33 | P = 0.0037 |
Sex | 1 | 12.2 | F (1, 38) = 11.0 | P = 0.0020 |
>CYP19A1: F vs. M | 38 | 2.19 | t = 4.95 | P < 0.0001 |
gene | 3 | 25.4 | F (3, 38) = 7.62 | P = 0.0004 |
>F: GPER vs. ESR1 | 38 | − 6.01 | t = 3.82 | P = 0.0029 |
>F: GPER vs. CYP19A1 | 38 | − 2.20 | t = 4.97 | P < 0.0001 |
>F: ESR2 vs. CYP19A1 | 38 | − 1.44 | t = 3.75 | P = 0.0035 |
Mammary (one-way) | ||||
Gene | 3 | 64.5 | F (3, 20) = 12.12 | P < 0.0001 |
>F: GPER vs. ESR1 | 20 | − 2.23 | t = 4.13 | P = 0.0031 |
>M: GPER vs. ESR1 | 20 | 2.98 | t = 5.163 | P = 0.0003 |
>M: GPER vs. ESR2 | 20 | 3.00 | t = 5.18 | P = 0.0003 |
Uterus (one-way) | ||||
Gene | 3 | 92.2 | F (3, 8) = 31.7 | P < 0.0001 |
>F: GPER vs. ESR1 | 8 | − 6.66 | t = 8.01 | P = 0.0003 |
>M: GPER vs. ESR1 | 8 | 6.80 | t = 8.14 | P = 0.0002 |
>M: GPER vs. ESR2 | 8 | 4.94 | t = 7.70 | P = 0.0003 |